Lipids & metabolic liver disease

Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training

Diabetes Obes MetabPublished Cross-sectional study and randomised controlled trial

Authors' conclusion

Impaired glycaemic regulation in MASLD is characterized by greater hepatic lipid saturation; however, this composition is not altered by 6 weeks of moderate-intensity exercise training.

Study context

Population
Men with MASLD (liver PDFF ≥5.56%)40 men in Part A
Participants
14 / 26 / 13 / 13
Comparison
IGR vs normal glycaemic regulation (NGR); exercise training vs non-exercise control in IGR
  • NGRn = 14reference
  • IGRn = 26
  • EXn = 13
  • Control (CON)n = 13reference
Primary endpoint
Hepatic saturated lipid index (SI), by proton magnetic resonance spectroscopy
Methodological detailsPart A cross-sectional, Part B randomized controlled trial, 6-week intervention
  • Part A cross-sectional
  • Part B randomized controlled trial
  • 6-week intervention

Primary result

As reported in the abstract

Hepatic SI and UI (Part A)
  • Hepatic SI higher and UI lower in IGR vs NGR
  • IGR vs NGR: P = 0.038

Secondary outcomes

OutcomeP value
Hepatic lipid composition and liver PDFF (Part B) · 6 weeksEX vs CON · unchangedP ≥ 0.257
FPG and VO2 peak (Part B) · 6 weeksEX vs CON · FPG reduced, VO2 peak increasedP ≤ 0.030

Hepatic lipid composition and liver PDFF (Part B) · 6 weeks

Hepatic lipid composition and liver PDFF unchanged after EX vs CON

Associations of hepatic lipid profile (Part A)

Lipid profile associated with higher HbA1c, fasting plasma glucose (FPG), homeostatic model assessment of insulin resistance (HOMA-IR) and CK18 M65 (rs)
≥0.320

ΔVO2 peak vs Δhepatic lipid indices (Part B)

ΔVO2 peak vs Δhepatic SI (r)
−0.433
ΔVO2 peak vs Δhepatic UI and PUI (r)
≥ 0.433

Original publication

Greater hepatic lipid saturation is associated with impaired glycaemic regulation in men with metabolic dysfunction‐associated steatotic liver disease but is not altered by 6 weeks of exercise training. Diabetes Obes Metab. Published 8 July 2024. doi:10.1111/dom.15755

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.